{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T18:29:23Z","timestamp":1780079363089,"version":"3.54.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00428-025-04157-8","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T16:30:59Z","timestamp":1752165059000},"page":"433-443","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Repeat biopsies in membranous lupus nephritis in the era of target antigen identification"],"prefix":"10.1007","volume":"487","author":[{"given":"Elodie","family":"Bernhard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamza","family":"Sakhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Oniszczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance","family":"Guillaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Limal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Allioua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narindra","family":"Jouan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Guillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Diet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Godeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Remy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Audard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nizar","family":"Joher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6015-3979","authenticated-orcid":false,"given":"Anissa","family":"Moktefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"key":"4157_CR1","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/rheumatology\/kev311","volume":"55","author":"JG Hanly","year":"2016","unstructured":"Hanly JG, O\u2019Keeffe AG, Su L et al (2016) The frequency and outcome of lupus nephritis: results from an international inception cohort study. Rheumatology (Oxford) 55:252\u2013262. https:\/\/doi.org\/10.1093\/rheumatology\/kev311","journal-title":"Rheumatology (Oxford)"},{"key":"4157_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1053\/j.ajkd.2019.10.017","volume":"76","author":"SV Parikh","year":"2020","unstructured":"Parikh SV, Almaani S, Brodsky S, Rovin BH (2020) Update on Lupus Nephritis: Core Curriculum 2020. Am J Kidney Dis 76:265\u2013281. https:\/\/doi.org\/10.1053\/j.ajkd.2019.10.017","journal-title":"Am J Kidney Dis"},{"key":"4157_CR3","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2023.09.002","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Lupus Nephritis Work Group","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Lupus Nephritis Work Group (2024) KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS. Kidney Int 105:S1\u2013S69. https:\/\/doi.org\/10.1016\/j.kint.2023.09.002","journal-title":"Kidney Int"},{"key":"4157_CR4","doi-asserted-by":"publisher","first-page":"v39","DOI":"10.1093\/rheumatology\/keaa381","volume":"59","author":"M Gasparotto","year":"2020","unstructured":"Gasparotto M, Gatto M, Binda V, Doria A, Moroni G (2020) Lupus nephritis: clinical presentations and outcomes in the 21st century. Rheumatology (Oxford) 59:v39\u2013v51. https:\/\/doi.org\/10.1093\/rheumatology\/keaa381","journal-title":"Rheumatology (Oxford)"},{"key":"4157_CR5","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1177\/0961203318770024","volume":"27","author":"PG Mody","year":"2018","unstructured":"Mody PG, Mody GM, Assounga A (2018) The clinical manifestations and response to treatment in South Africans with lupus nephritis. Lupus 27:1207\u20131217. https:\/\/doi.org\/10.1177\/0961203318770024","journal-title":"Lupus"},{"key":"4157_CR6","doi-asserted-by":"publisher","first-page":"A277","DOI":"10.1016\/j.autrev.2009.12.008","volume":"9","author":"AT Borchers","year":"2010","unstructured":"Borchers AT, Naguwa SM, Shoenfeld Y, Gershwin ME (2010) The geoepidemiology of systemic lupus erythematosus. Autoimmun Rev 9:A277\u2013A287. https:\/\/doi.org\/10.1016\/j.autrev.2009.12.008","journal-title":"Autoimmun Rev"},{"key":"4157_CR7","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1136\/annrheumdis-2017-212732","volume":"77","author":"G Moroni","year":"2018","unstructured":"Moroni G, Vercelloni PG, Quaglini S et al (2018) Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis. Ann Rheum Dis 77:1318\u20131325. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212732","journal-title":"Ann Rheum Dis"},{"key":"4157_CR8","doi-asserted-by":"publisher","unstructured":"Kharouf F, Li Q, Whittall Garcia LP, Jauhal A, Gladman DD, Touma Z (2024) Short and long-term outcomes of patients with pure membranous lupus nephritis compared to patients with proliferative disease. Rheumatology (Oxford).https:\/\/doi.org\/10.1093\/rheumatology\/keae436","DOI":"10.1093\/rheumatology\/keae436"},{"key":"4157_CR9","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.semarthrit.2011.08.002","volume":"41","author":"G Moroni","year":"2012","unstructured":"Moroni G, Quaglini S, Gravellone L et al (2012) Membranous nephropathy in systemic lupus erythematosus: long-term outcome and prognostic factors of 103 patients. Semin Arthritis Rheum 41:642\u2013651. https:\/\/doi.org\/10.1016\/j.semarthrit.2011.08.002","journal-title":"Semin Arthritis Rheum"},{"key":"4157_CR10","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2215\/CJN.05040513","volume":"9","author":"SV Parikh","year":"2014","unstructured":"Parikh SV, Nagaraja HN, Hebert L, Rovin BH (2014) Renal flare as a predictor of incident and progressive CKD in patients with lupus nephritis. Clin J Am Soc Nephrol 9:279\u2013284. https:\/\/doi.org\/10.2215\/CJN.05040513","journal-title":"Clin J Am Soc Nephrol"},{"key":"4157_CR11","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1093\/ndt\/gfx019","volume":"33","author":"A Pakozdi","year":"2018","unstructured":"Pakozdi A, Pyne D, Sheaff M, Rajakariar R (2018) Utility of a repeat renal biopsy in lupus nephritis: a single centre experience. Nephrol Dial Transplant 33:507\u2013513. https:\/\/doi.org\/10.1093\/ndt\/gfx019","journal-title":"Nephrol Dial Transplant"},{"key":"4157_CR12","doi-asserted-by":"publisher","unstructured":"Mercadal L, Montcel ST, Nochy D et al (2002) Factors affecting outcome and prognosis in membranous lupus nephropathy. Nephrol Dial Transplant 17:1771\u20131778. https:\/\/doi.org\/10.1093\/ndt\/17.10.1771","DOI":"10.1093\/ndt\/17.10.1771"},{"key":"4157_CR13","doi-asserted-by":"publisher","first-page":"986","DOI":"10.2215\/CJN.00350122","volume":"17","author":"C Wang","year":"2022","unstructured":"Wang C, Liu Y, Zhang M et al (2022) Glomerular exostosin as a subtype and activity marker of class 5 lupus nephritis. Clin J Am Soc Nephrol 17:986\u2013993. https:\/\/doi.org\/10.2215\/CJN.00350122","journal-title":"Clin J Am Soc Nephrol"},{"issue":"24","key":"4157_CR14","doi-asserted-by":"publisher","first-page":"e7099","DOI":"10.1097\/MD.0000000000007099","volume":"96","author":"J Narv\u00e1ez","year":"2017","unstructured":"Narv\u00e1ez J, Ricse M, Gom\u00e0 M et al (2017) The value of repeat biopsy in lupus nephritis flares. Medicine (Baltimore) 96(24):e7099. https:\/\/doi.org\/10.1097\/MD.0000000000007099","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"4157_CR15","doi-asserted-by":"publisher","first-page":"e000689","DOI":"10.1136\/lupus-2022-000689","volume":"9","author":"M Gatto","year":"2022","unstructured":"Gatto M, Radice F, Saccon F et al (2022) Clinical and histological findings at second but not at first kidney biopsy predict end-stage kidney disease in a large multicentric cohort of patients with active lupus nephritis. Lupus Sci Med 9(1):e000689. https:\/\/doi.org\/10.1136\/lupus-2022-000689","journal-title":"Lupus Sci Med"},{"issue":"1","key":"4157_CR16","doi-asserted-by":"publisher","first-page":"e000004","DOI":"10.1136\/lupus-2013-000004","volume":"1","author":"G Greloni","year":"2014","unstructured":"Greloni G, Scolnik M, Marin J et al (2014) Value of repeat biopsy in lupus nephritis flares. Lupus Sci Med 1(1):e000004. https:\/\/doi.org\/10.1136\/lupus-2013-000004","journal-title":"Lupus Sci Med"},{"key":"4157_CR17","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1093\/rheumatology\/keab775","volume":"61","author":"A Fava","year":"2022","unstructured":"Fava A, Fenaroli P, Rosenberg A et al (2022) History of proliferative glomerulonephritis predicts end stage kidney disease in pure membranous lupus nephritis. Rheumatology (Oxford) 61:2483\u20132493. https:\/\/doi.org\/10.1093\/rheumatology\/keab775","journal-title":"Rheumatology (Oxford)"},{"key":"4157_CR18","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1093\/ndt\/gft272","volume":"28","author":"F Pagni","year":"2013","unstructured":"Pagni F, Galimberti S, Goffredo P et al (2013) The value of repeat biopsy in the management of lupus nephritis: an international multicentre study in a large cohort of patients. Nephrol Dial Transplant 28:3014\u20133023. https:\/\/doi.org\/10.1093\/ndt\/gft272","journal-title":"Nephrol Dial Transplant"},{"key":"4157_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.clim.2016.11.019","volume":"185","author":"C Arriens","year":"2017","unstructured":"Arriens C, Chen S, Karp DR et al (2017) Prognostic significance of repeat biopsy in lupus nephritis: Histopathologic worsening and a short time between biopsies is associated with significantly increased risk for end stage renal disease and death. Clin Immunol 185:3\u20139. https:\/\/doi.org\/10.1016\/j.clim.2016.11.019","journal-title":"Clin Immunol"},{"key":"4157_CR20","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/s0272-6386(99)70082-x","volume":"34","author":"G Moroni","year":"1999","unstructured":"Moroni G, Pasquali S, Quaglini S, Banfi G, Casanova S, Maccario M, Zucchelli P, Ponticelli C (1999) Clinical and prognostic value of serial renal biopsies in lupus nephritis. Am J Kidney Dis 34:530\u2013539. https:\/\/doi.org\/10.1016\/s0272-6386(99)70082-x","journal-title":"Am J Kidney Dis"},{"key":"4157_CR21","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.kint.2023.06.032","volume":"104","author":"S Sethi","year":"2023","unstructured":"Sethi S, Beck LH Jr, Glassock RJ et al (2023) Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification. Kidney Int 104:1092\u20131102. https:\/\/doi.org\/10.1016\/j.kint.2023.06.032","journal-title":"Kidney Int"},{"key":"4157_CR22","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1681\/ASN.2018080852","volume":"30","author":"S Sethi","year":"2019","unstructured":"Sethi S, Madden BJ, Debiec H et al (2019) exostosin 1\/exostosin 2-associated membranous nephropathy. J Am Soc Nephrol 30:1123\u20131136. https:\/\/doi.org\/10.1681\/ASN.2018080852","journal-title":"J Am Soc Nephrol"},{"key":"4157_CR23","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1681\/ASN.2020081181","volume":"32","author":"A Ravindran","year":"2021","unstructured":"Ravindran A, Casal Moura M, Fervenza FC et al (2021) In Patients with membranous lupus nephritis, exostosin-positivity and exostosin-negativity represent two different phenotypes. J Am Soc Nephrol 32:695\u2013706. https:\/\/doi.org\/10.1681\/ASN.2020081181","journal-title":"J Am Soc Nephrol"},{"key":"4157_CR24","doi-asserted-by":"publisher","unstructured":"Sa\u00efdi M, Broch\u00e9riou I, Est\u00e8ve E et al (2021) The exostosin immunohistochemical status differentiates lupus membranous nephropathy subsets with different outcomes. Kidney Int Rep 6(7):1977\u20131980. https:\/\/doi.org\/10.1016\/j.ekir.2021.04.025","DOI":"10.1016\/j.ekir.2021.04.025"},{"key":"4157_CR25","doi-asserted-by":"publisher","unstructured":"Li H, Lan P, Yu X et al (2022) Analysis of the expression of exostosins and clinicopathological features in membranous lupus nephritis in a Chinese Cohort. Kidney Int Rep 7:2295\u20132298.https:\/\/doi.org\/10.1016\/j.ekir.2022.07.164","DOI":"10.1016\/j.ekir.2022.07.164"},{"key":"4157_CR26","doi-asserted-by":"publisher","unstructured":"Xia X, Li S, Wang Z, et al (2024) Glomerular exostosin-positivity is associated with disease activity and outcomes in patients with membranous lupus nephritis. Kidney Int Rep 9:1040\u20131046. https:\/\/doi.org\/10.1016\/j.ekir.2024.01.008","DOI":"10.1016\/j.ekir.2024.01.008"},{"key":"4157_CR27","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1007\/s10067-024-07043-x","volume":"43","author":"MF Zavala-Miranda","year":"2024","unstructured":"Zavala-Miranda MF, Sobrino-Vargas AM, Hern\u00e1ndez-Andrade A et al (2024) Exostosin-1\/exostosin-2 expression and favorable kidney outcomes in lupus nephritis: a retrospective cohort study. Clin Rheumatol 43:2533\u20132540. https:\/\/doi.org\/10.1007\/s10067-024-07043-x","journal-title":"Clin Rheumatol"},{"key":"4157_CR28","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s00428-021-03164-9","volume":"479","author":"Y Wada","year":"2021","unstructured":"Wada Y, Iyoda M, Suzuki T et al (2021) Immunopathological analysis of the expression of glomerular exostosin 1 and exostosin 2 in Japanese patients with lupus nephritis. Virchows Arch 479:997\u20131005. https:\/\/doi.org\/10.1007\/s00428-021-03164-9","journal-title":"Virchows Arch"},{"issue":"1","key":"4157_CR29","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.kint.2020.09.016","volume":"100","author":"TN Caza","year":"2021","unstructured":"Caza TN, Hassen SI, Kuperman M et al (2021) Neural cell adhesion molecule 1 is a novel autoantigen in membranous lupus nephritis. Kidney Int 100(1):171\u2013181. https:\/\/doi.org\/10.1016\/j.kint.2020.09.016","journal-title":"Kidney Int"},{"issue":"1","key":"4157_CR30","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/ndt\/gfae148","volume":"40","author":"X Xia","year":"2024","unstructured":"Xia X, Li S, Jia X et al (2024) Clinicopathological phenotype and outcomes of NCAM-1+ membranous lupus nephritis. Nephrol Dial Transplant 40(1):193\u2013205. https:\/\/doi.org\/10.1093\/ndt\/gfae148","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"4157_CR31","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1093\/ndt\/gfac058","volume":"38","author":"PP Miller","year":"2023","unstructured":"Miller PP, Caza T, Larsen CP, Charu V (2023) EXT1 and NCAM1-associated membranous lupus nephritis in a cohort of patients undergoing repeat kidney biopsies. Nephrol Dial Transplant 38(2):396\u2013404. https:\/\/doi.org\/10.1093\/ndt\/gfac058","journal-title":"Nephrol Dial Transplant"},{"key":"4157_CR32","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1016\/j.semarthrit.2019.09.009","volume":"49","author":"M Aringer","year":"2019","unstructured":"Aringer M (2019) EULAR\/ACR classification criteria for SLE. Semin Arthritis Rheum 49:S14\u2013S17. https:\/\/doi.org\/10.1016\/j.semarthrit.2019.09.009","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"4157_CR33","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1053\/j.ajkd.2015.07.006","volume":"66","author":"AB Fogo","year":"2015","unstructured":"Fogo AB, Lusco MA, Najafian B, Alpers CE (2015) AJKD atlas of renal pathology: membranous nephropathy. Am J Kidney Dis 66(3):e15\u2013e17. https:\/\/doi.org\/10.1053\/j.ajkd.2015.07.006","journal-title":"Am J Kidney Dis"},{"key":"4157_CR34","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1046\/j.1523-1755.2001.00492.x","volume":"59","author":"GS Hill","year":"2001","unstructured":"Hill GS, Delahousse M, Nochy D, R\u00e9my P, Mignon F, M\u00e9ry JP, Bari\u00e9ty J (2001) Predictive power of the second renal biopsy in lupus nephritis: significance of macrophages. Kidney Int 59:304\u2013316. https:\/\/doi.org\/10.1046\/j.1523-1755.2001.00492.x","journal-title":"Kidney Int"},{"key":"4157_CR35","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1523-1755.2004.00443.x","volume":"65","author":"JJ Weening","year":"2004","unstructured":"Weening JJ, D\u2019Agati VD, Schwartz MM et al (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 65:521\u2013530. https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00443.x","journal-title":"Kidney Int"},{"key":"4157_CR36","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.kint.2017.11.023","volume":"93","author":"IM Bajema","year":"2018","unstructured":"Bajema IM, Wilhelmus S, Alpers CE et al (2018) Revision of the international society of nephrology\/renal pathology society classification for lupus nephritis: clarification of definitions, and modified national institutes of health activity and chronicity indices. Kidney Int 93:789\u2013796. https:\/\/doi.org\/10.1016\/j.kint.2017.11.023","journal-title":"Kidney Int"},{"key":"4157_CR37","doi-asserted-by":"publisher","first-page":"e002386","DOI":"10.1136\/rmdopen-2022-002386","volume":"8","author":"A Enfrein","year":"2022","unstructured":"Enfrein A, Pirson V, Le Guern V et al (2022) Worse long-term renal outcome of lupus nephritis patients of African descent living in Europe. RMD Open 8:e002386. https:\/\/doi.org\/10.1136\/rmdopen-2022-002386","journal-title":"RMD Open"},{"key":"4157_CR38","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/rheumatology\/keaa103","volume":"59","author":"F Farinha","year":"2020","unstructured":"Farinha F, Pepper RJ, Oliveira DG, McDonnell T, Isenberg DA, Rahman A (2020) Outcomes of membranous and proliferative lupus nephritis - analysis of a single-centre cohort with more than 30 years of follow-up. Rheumatology (Oxford) 59:3314\u20133323. https:\/\/doi.org\/10.1093\/rheumatology\/keaa103","journal-title":"Rheumatology (Oxford)"},{"key":"4157_CR39","doi-asserted-by":"publisher","first-page":"734","DOI":"10.2215\/CJN.10601016","volume":"12","author":"EC Rijnink","year":"2017","unstructured":"Rijnink EC, Teng YKO, Wilhelmus S et al (2017) Clinical and histopathologic characteristics associated with renal outcomes in lupus nephritis. Clin J Am Soc Nephrol 12:734\u2013743. https:\/\/doi.org\/10.2215\/CJN.10601016","journal-title":"Clin J Am Soc Nephrol"},{"key":"4157_CR40","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.2215\/CJN.0000000000000556","volume":"19","author":"A Ramu","year":"2024","unstructured":"Ramu A, Santana de Roberts R, Hti Lar Seng NS et al (2024) The role of repeat kidney biopsies in lupus nephritis in a largely black and Hispanic population. Clin J Am Soc Nephrol 19:1643\u20131645. https:\/\/doi.org\/10.2215\/CJN.0000000000000556","journal-title":"Clin J Am Soc Nephrol"},{"key":"4157_CR41","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.kint.2023.01.001","volume":"103","author":"TN Caza","year":"2023","unstructured":"Caza TN, Storey AJ, Hassen SI et al (2023) Discovery of seven novel putative antigens in membranous nephropathy and membranous lupus nephritis identified by mass spectrometry. Kidney Int 103:593\u2013606. https:\/\/doi.org\/10.1016\/j.kint.2023.01.001","journal-title":"Kidney Int"},{"key":"4157_CR42","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.3899\/jrheum.180773","volume":"46","author":"C Li","year":"2019","unstructured":"Li C, Yap DYH, Chan G et al (2019) Clinical outcomes and clinico-pathological correlations in lupus nephritis with kidney biopsy showing thrombotic microangiopathy. J Rheumatol 46:1478\u20131484. https:\/\/doi.org\/10.3899\/jrheum.180773","journal-title":"J Rheumatol"},{"key":"4157_CR43","doi-asserted-by":"publisher","first-page":"R12","DOI":"10.1186\/ar4142","volume":"15","author":"D Song","year":"2013","unstructured":"Song D, Wu LH, Wang FM et al (2013) The spectrum of renal thrombotic microangiopathy in lupus nephritis. Arthritis Res Ther 15:R12. https:\/\/doi.org\/10.1186\/ar4142","journal-title":"Arthritis Res Ther"},{"key":"4157_CR44","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/ki.2012.409","volume":"83","author":"LH Wu","year":"2013","unstructured":"Wu LH, Yu F, Tan Y et al (2013) Inclusion of renal vascular lesions in the 2003 ISN\/RPS system for classifying lupus nephritis improves renal outcome predictions. Kidney Int 83:715\u2013723. https:\/\/doi.org\/10.1038\/ki.2012.409","journal-title":"Kidney Int"},{"key":"4157_CR45","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1177\/0961203319828516","volume":"28","author":"M Weidenbusch","year":"2019","unstructured":"Weidenbusch M, Bai Y, Eder J, Anders HJ, Lupus Nephritis Trials Network (2019) Refractory lupus nephritis: a survey. Lupus 28:455\u2013464. https:\/\/doi.org\/10.1177\/0961203319828516","journal-title":"Lupus"},{"key":"4157_CR46","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1093\/ndt\/gfab351","volume":"38","author":"HJ Anders","year":"2023","unstructured":"Anders HJ, Loutan J, Bruchfeld A et al (2023) The management of lupus nephritis as proposed by EULAR\/ERA 2019 versus KDIGO 2021. Nephrol Dial Transplant 38:551\u2013561. https:\/\/doi.org\/10.1093\/ndt\/gfab351","journal-title":"Nephrol Dial Transplant"},{"key":"4157_CR47","doi-asserted-by":"publisher","first-page":"390 \u2013396","DOI":"10.1002\/art.38220","volume":"66","author":"BI Freedman","year":"2014","unstructured":"Freedman BI, Langefeld CD, Andringa KK et al (2014) End-stage renal disease in African Americans with lupus nephritis is associated with APOL1. Arthritis Rheumatol 66:390\u2013396. https:\/\/doi.org\/10.1002\/art.38220","journal-title":"Arthritis Rheumatol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04157-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-025-04157-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04157-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T02:18:09Z","timestamp":1756347489000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-025-04157-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["4157"],"URL":"https:\/\/doi.org\/10.1007\/s00428-025-04157-8","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"10 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical standards of the Helsinki Declaration, and with the approval of the local institutional review board (IRB 412 Mondor No. 00003835) and the Comit\u00e9 de Protection des Personnes d\u2019Ile de France IV (No. 2016\/25NICB).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}